Appearing on the Health Care Rounds podcast, Evolent Senior Director for Value Transformation Kamal Golla explains why value-based specialty care is primed for growth. 
About 1 of every 3 patients gets referred by their primary care provider to a specialist. And 40-50% of all outpatient visits are with specialists. Evolent Senior Medical Director for Value Transformation Vishnukamal Golla joined the Health Care Rounds podcast to discuss trends in value-based specialty care, including the need to integrate care across settings and providers.
Listen on your favorite podcast platform:
Can’t listen to the whole episode? Fast forward to some highlights:
-
The state of value-based care – the headwinds it faces as well as the forces moving it forward (10:05)
-
The growth in utilization of specialty care and the challenges that growth poses for care coordination (12:35)
-
The similarities and differences between value-based programs in primary care and specialty care (18:35)
-
The perverse incentives helping to drive the use of costly drugs (24:54)
-
Why quality of care should be the first, second and third consideration when evaluating high-cost oncology drugs. (28:20)
-
The growing importance for health plans to improve the patient and member experience, and the trends driving that (31:40)
-
Why we need to retire the “blunt instruments” focused on short-term cost savings for value-based programs spanning the continuum of care. (33:15)
-
The ways that risk-based arrangements enable innovation, such as care navigation, to improve management of the most complex conditions (34:58)
-
The trends encouraging risk-bearing organizations to look more at specialty care as an opportunity to drive better quality and value (38:27)
